Add to ORKGActivity of moxifloxacin against Bacteroides fragilis and Escherichia coli in an in vitro pharmacokinetic/ pharmacodynamic model employing pure and mixed culture
New agents are urgently needed to meet the threat of multiple drug-resistant tuberculosis and to man...
Moxifloxacin is an 8-methoxyquinolone compound with activity against a wide range of bacteria. We te...
Objective: The purpose of this study was to explore the population pharmacokinetic features of moxif...
ObjectiveTo evaluate the in vitro antibacterial activity of moxifloxacinin in comparison to that of ...
AbstractObjectiveTo assess the antibacterial action of moxifloxacin on Haemophilus influenzae and Mo...
doi:10.1093/jac/dkl356 Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneum...
Objectives: To compare in an in vitro kinetic model the pharmacodynamics of moxifloxacin and levoflo...
Moxifloxacin (CAS 186286-86-8) is a recent fluoroquinolone addressed to the treatment of respiratory...
Objectives: The aim of this study was to determine the intracellular activity of moxifloxacin agains...
Objectives: Moxifloxacin is recommended in the empirical treatment of infections involving Gram-nega...
Moxifloxacin is a recent fluoroquinolone with an antibacterial spectrum encompassing both aerobic Gr...
The article presents a comparison between microbiological and high performance liquid chromatographi...
Objectives: Moxifloxacin is recommended in the empirical treatment of infections involving Gram-nega...
Le traitement des infections intracellulaires nécessite d'utiliser des antibiotiques actifs sur les ...
AbstractBackground:In intra-abdominal infections, the activity of antimicrobial agents against Bacte...
New agents are urgently needed to meet the threat of multiple drug-resistant tuberculosis and to man...
Moxifloxacin is an 8-methoxyquinolone compound with activity against a wide range of bacteria. We te...
Objective: The purpose of this study was to explore the population pharmacokinetic features of moxif...
ObjectiveTo evaluate the in vitro antibacterial activity of moxifloxacinin in comparison to that of ...
AbstractObjectiveTo assess the antibacterial action of moxifloxacin on Haemophilus influenzae and Mo...
doi:10.1093/jac/dkl356 Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneum...
Objectives: To compare in an in vitro kinetic model the pharmacodynamics of moxifloxacin and levoflo...
Moxifloxacin (CAS 186286-86-8) is a recent fluoroquinolone addressed to the treatment of respiratory...
Objectives: The aim of this study was to determine the intracellular activity of moxifloxacin agains...
Objectives: Moxifloxacin is recommended in the empirical treatment of infections involving Gram-nega...
Moxifloxacin is a recent fluoroquinolone with an antibacterial spectrum encompassing both aerobic Gr...
The article presents a comparison between microbiological and high performance liquid chromatographi...
Objectives: Moxifloxacin is recommended in the empirical treatment of infections involving Gram-nega...
Le traitement des infections intracellulaires nécessite d'utiliser des antibiotiques actifs sur les ...
AbstractBackground:In intra-abdominal infections, the activity of antimicrobial agents against Bacte...
New agents are urgently needed to meet the threat of multiple drug-resistant tuberculosis and to man...
Moxifloxacin is an 8-methoxyquinolone compound with activity against a wide range of bacteria. We te...
Objective: The purpose of this study was to explore the population pharmacokinetic features of moxif...